EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma

Maoqing Jiang iD, Xiuyu Guo, Ping Chen, Xiaohui Zhang, Qiaoling Gao, Jingfeng Zhang, Jianjun Zheng

PeerJ · 2024

DOI: 10.7717/peerj.16807 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Maoqing Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exploration Project of Natural Science Foundation of Zhejiang Province, Ningbo Youth Science and Technology Innovation Leading Talent Project, Zhu Xiu Shan Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The objective of this study was to investigate the prognostic significance of total metabolic tumor volume (TMTV) derived from baseline 18 F-2-fluoro-2-deoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT), in conjunction with epidermal growth factor receptor (EGFR) mutation status, among patients with lung adenocarcinoma (LUAD).

Methods

We performed a retrospective analysis on 141 patients with LUAD (74 males, 67 females, median age 67 (range 34–86)) who underwent 18 F-FDG PET/CT and had their EGFR mutation status determined. Optimal cutoff points for TMTV were determined using time-dependent receiver operating characteristic curve analysis. The survival difference was compared using Cox regression analysis and Kaplan‒Meier curves.

Results

The EGFR mutant patients ( n = 79, 56.0%) exhibited significantly higher 2-year progression-free survival (PFS) and overall survival (OS) rates compared to those with EGFR wild-type ( n = 62, 44.0%), with rates of 74.2% vs 69.2% ( P = 0.029) and 86.1% vs 67.7% ( P = 0.009), respectively. The optimal cutoff values of TMTV were 36.42 cm 3 for PFS and 37.51 cm 3 for OS. Patients with high TMTV exhibited significantly inferior 2-year PFS and OS, with rates of 22.4% and 38.1%, respectively, compared to those with low TMTV, who had rates of 85.8% and 95.0% (both P < 0.001). In both the EGFR mutant and wild-type groups, patients exhibiting high TMTV demonstrated significantly inferior 2-year PFS and OS compared to those with low TMTV. In multivariate analysis, EGFR mutation status (hazard ratio, HR, 0.41, 95% confidence interval, CI [0.18–0.94], P = 0.034) and TMTV (HR 8.08, 95% CI [2.34–28.0], P < 0.001) were independent prognostic factors of OS, whereas TMTV was also an independent prognosticator of PFS (HR 2.59, 95% CI [1.30–5.13], P = 0.007).

Conclusion

Our study demonstrates that the integration of TMTV on baseline 18 F-FDG PET/CT with EGFR mutation status improves the accuracy of prognostic evaluation for patients with LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsAgedFemaleHumansMaleErbB ReceptorsFluorodeoxyglucose F18MutationPositron Emission Tomography Computed TomographyPrognosisRetrospective StudiesTumor BurdenAdultMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

18F-2-fluoro-2-deoxyglucoseComputed tomographyEpidermal growth factor receptorLung adenocarcinomaMetabolic tumor volumePositron emission tomography

Substanzen

EGFR protein, humanErbB ReceptorsFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Radiology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Department of Nuclear Medicine, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
  • Department of Nephrology, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.

ORCID-Profile: Maoqing Jiang

Förderung

  • Exploration Project of Natural Science Foundation of Zhejiang Province
  • Ningbo Youth Science and Technology Innovation Leading Talent Project
  • Zhu Xiu Shan Talent Project
  • Ningbo Clinical Research Center for Medicine Imaging
  • Provincial and Municipal Co-construction Key Discipline for Medical Imaging

Zitieren

APA

Jiang, M., Guo, X., Chen, P., Zhang, X., Gao, Q., Zhang, J., & Zheng, J. (2024). Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma. PeerJ. https://doi.org/10.7717/peerj.16807

Vancouver

Jiang M, Guo X, Chen P, Zhang X, Gao Q, Zhang J, et al. Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma. PeerJ. 2024. doi:10.7717/peerj.16807

BibTeX
@article{Jiang2024,
  author = {Jiang, Maoqing and Guo, Xiuyu and Chen, Ping and Zhang, Xiaohui and Gao, Qiaoling and Zhang, Jingfeng and Zheng, Jianjun},
  title = {Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.16807}
}
Kostenlos starten →